Piramal Pharma Ltd. has confirmed the reappointment of Jairaj Purandare as a Non-Executive Independent Director, effective from February 9, 2026. This decision was endorsed by the company’s Board of Directors during their recent meeting and awaits shareholder approval.

Background and Experience

Jairaj Purandare, who has been part of the Piramal Pharma board since 2021, brings a wealth of experience in auditing, taxation, and advisory services. He is the founder and chairman of JMP Advisors Pvt Ltd. His prior roles include significant positions at leading firms such as:

• Regional Managing Partner at PricewaterhouseCoopers (PwC) India
• Chairman at Ernst & Young India (EY)
• Country Head of Tax & Business Advisory at Andersen India

Strategic Importance of Reappointment

Purandare’s continued role is seen as vital for bolstering the company’s governance and strategic direction, particularly in light of the evolving regulatory landscape. His reappointment exemplifies Piramal Pharma’s dedication to upholding high standards of corporate governance.